Lab-cultured cardiac cells

Three types of human heart cells have been grown from cultures derived from embryonic stem cells, by a team of Canadian, US and UK scientists.

During the research, when a mix of the cells was transplanted into mice with simulated heart disease, the animals’ heart function was significantly improved, according to research published in the journal Nature.
The embryonic stem cell cultures were carefully supplied with a staged cocktail of growth factors and other molecules involved in development, and grew into immature versions of cardiomyocytes, endothelial cells and vascular smooth muscle cells, each important constituents of heart muscle. ‘This development means that we can efficiently and accurately make different types of human heart cells for use in both basic and clinical research, said researcher Dr Gordon Keller, of the McEwen Centre for Regenerative Medicine in Toronto. ‘The immediate impact of this is significant, as we now have an unlimited supply of these cells to study how they develop, how they function and how they respond to different drugs. In the future, the cells may also be very effective in developing new strategies for repairing damaged hearts, following a heart attack.’

30.04.2008

More on the subject:

Related articles

Photo

News • Targeting early versions

A 'head start' in the race against pancreatic cancer

Fighting pancreatic cancer can feel like a race against time. A new discovery could give clinicians a head start - by targeting precancerous lesions before they become much more aggressive.

Photo

Sponsored • Laboratory automation

Connect, automate and innovate your lab through SMART Automation 

In today’s fast-paced healthcare landscape, efficiency and accuracy are essential in overcoming workload challenges. Pathology laboratories are under pressure to keep up with growing demands, all…

Photo

News • Automated evaluation

Robot enhances side-effect monitoring after cardiac arrhythmia treatment

A newly-developed robot can detect medication side-effects in patients after heart arrhythmia treatment faster than a human doctor, while reducing the number of follow-up tests.

Related products

Subscribe to Newsletter